Stericycle Stock Price, News & Analysis (NASDAQ:SRCL)

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SRCL shares.
View SRCL analyst ratings or view top-rated stocks.

4 brokers have issued 12-month target prices for Stericycle's stock. Their SRCL share price targets range from $45.00 to $70.00. On average, they predict the company's stock price to reach $56.50 in the next twelve months. This suggests a possible upside of 17.4% from the stock's current price.
View analysts price targets for SRCL or view top-rated stocks among Wall Street analysts.

Stericycle's stock was trading at $49.89 at the beginning of the year. Since then, SRCL shares have decreased by 3.5% and is now trading at $48.14.
View the best growth stocks for 2023 here.

Stericycle saw a increase in short interest in November. As of November 15th, there was short interest totaling 3,230,000 shares, an increase of 40.4% from the October 31st total of 2,300,000 shares. Based on an average daily volume of 523,100 shares, the short-interest ratio is currently 6.2 days.
View Stericycle's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our SRCL earnings forecast.

Stericycle, Inc. (NASDAQ:SRCL) issued its earnings results on Thursday, November, 2nd. The business services provider reported $0.43 earnings per share for the quarter, meeting analysts' consensus estimates of $0.43. The business services provider earned $653.50 million during the quarter, compared to analysts' expectations of $679.03 million. Stericycle had a positive trailing twelve-month return on equity of 7.36% and a negative net margin of 0.17%. Stericycle's quarterly revenue was down 5.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.65 earnings per share.

ETFs with the largest weight of Stericycle (NASDAQ:SRCL) stock in their portfolio include VanEck Environmental Services ETF (EVX), Ecofin US Renewables Infrastructure (RNEW), iShares Environmental Infrastructure and Industrials ETF (EFRA), VanEck Morningstar SMID Moat ETF (SMOT), Schwab Ariel ESG ETF (SAEF), Qraft AI-Enhanced Next Value ETF (NVQ), Hypatia Women CEO ETF (WCEO) and First Trust Utilities AlphaDEX Fund (FXU).

132 employees have rated Stericycle Chief Executive Officer Cindy Miller on Glassdoor.com. Cindy Miller has an approval rating of 74% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Stericycle investors own include Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), QUALCOMM (QCOM), Johnson & Johnson (JNJ), AbbVie (ABBV), Fastenal (FAST) and Gilead Sciences (GILD).

Stericycle's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Clarkston Capital Partners LLC (7.05%), Black Creek Investment Management Inc. (5.94%), Ariel Investments LLC (4.68%), Impax Asset Management Group plc (3.23%), JPMorgan Chase & Co. (2.70%) and Mondrian Investment Partners LTD (2.12%). Insiders that own company stock include Daniel Ginnetti, Naren K Gursahaney and Stephen Cory White.
View institutional ownership trends.

Shares of SRCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.